Showing results (941-950 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|December 9, 1995
Drug pricing and reimbursement in France. Towards a new model?C Le PenPharmacoeconomics|December 9, 1995
A framework for cost-sharing policy analysisR J Rubin, D N MendelsonPharmacoeconomics|August 5, 1996
Dynamic competition as an exploratory model of healthcare policy for the antihypertensive marketR J Bonk, M J Myers, C H Knowlton, et al.Pharmacoeconomics|September 4, 1996
A review of the progress towards developing health-related quality-of-life instruments for international clinical studies and outcomes researchR T Anderson, N K Aaronson, M Bullinger, et al.Pharmacoeconomics|September 4, 1996
Full-cost determination of different levels of care in the intensive care unit. An activity-based costing approachJ J Doyle, J P Casciano, S R Arikian, et al.Pharmacoeconomics|October 4, 1996
Approaches to rationing drugs in hospitals. An Australian perspectiveF Bochner, N G Burgess, E D MartinPharmacoeconomics|April 7, 1997
The economic aspects of drug delivery in asthmaR J Massie, C M MellisPharmacoeconomics|April 7, 1997
Autologous peripheral blood progenitor-cell transplantation versus autologous bone marrow transplantation for adults and children with non-leukaemic malignant disease. A randomised economic studyA G Le Corroller, C Faucher, A Auperin, et al.Pharmacoeconomics|December 8, 1996
A multinational investigation of the impact of subcutaneous sumatriptan. III: Workplace productivity and non-workplace activityP Cortelli, C Dahlöf, J Bouchard, et al.Pharmacoeconomics|August 18, 2000
The cost effectiveness of misoprostol prophylaxis alongside long-term nonsteroidal anti-inflammatory drugs. Implications of the MUCOSA trialP J Davey, E MeyerPageof 336